Please try another search
Genomics BioSci & Tech. Co.,Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 396.14 million compared to TWD 419 million a year ago. Net loss was TWD 168.07 million compared to net income of TWD 71.6 million a year ago. Basic loss per share from continuing operations was TWD 2.36 compared to basic earnings per share from continuing operations of TWD 1.13 a year ago. Diluted loss per share from continuing operations was TWD 2.36 compared to diluted earnings per share from continuing operations of TWD 1.13 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | ||||
Gross Profit | ||||
Operating Income | ||||
Net Income | -44.88 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 1133.84 | |||
Total Liabilities | ||||
Total Equity |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | ||||
Cash From Investing Activities | ||||
Cash From Financing Activities | ||||
Net Change in Cash |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review